| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |